June 5, 2025 | BALTIMORE -Complete Omics Inc. is proud to announce a successful debut at the American Society for Mass Spectrometry (ASMS) 2025 Annual Meeting, held in Baltimore, Maryland.
At this premier global event for mass spectrometry and analytical innovation, our team presented groundbreaking advances in clinical proteomics and multi-omics diagnostics. The spotlight was on our proprietary platforms—Complete360®, Valid-NEO®, and CompleteCohort™—which collectively represent a transformative leap in attomole-level sensitivity, reproducibility, and real-world clinical applicability.
We were honored to showcase our work alongside some of the world’s most respected researchers in omics science. The presentations highlighted our team’s continued dedication to accelerating the development of next-generation diagnostic tools for early disease detection, precision medicine, and population-scale health monitoring.
This milestone would not have been possible without the vision and leadership of our co-founder Dr. Hui Zhang, and founding scientists Dr. Raghothama Chaerkady and Dr. Liang Zhao, whose pioneering work continues to shape the frontier of personalized diagnostics.
We extend our sincere thanks to our collaborators, partners, and all the attendees we engaged with at ASMS 2025. Your enthusiasm and support fuel our mission, and we look forward to building on this momentum together.
Stay tuned as we continue pushing the boundaries of what’s possible in clinical proteomics.
